China Shengmu Organic Milk (SEHK:1432) opened FY 2025 with first half revenue of CNY 1,444.3 million and basic EPS of CNY 0.005844 loss per share, setting a cautious tone for investors focused on profitability. Over the last three reported half year periods, revenue moved from CNY 1,490.7 million in 1H 2024 to CNY 1,635.5 million in 2H 2024, then to CNY 1,444.3 million in 1H 2025. Basic EPS shifted from a CNY 0.017588 loss to CNY 0.00948, before settling at a CNY 0.005844 loss, leaving margins under pressure and putting the quality of any future improvement in the spotlight.
See our full analysis for China Shengmu Organic Milk.With the headline numbers on the table, the next step is to see how these results line up with the most common narratives around China Shengmu Organic Milk, and where the data calls those stories into question.
Curious how numbers become stories that shape markets? Explore Community Narratives
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on China Shengmu Organic Milk's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
If the cautious tone in the numbers feels familiar, that is exactly why it is worth checking the figures yourself and forming your own take. Before you decide how this all fits your risk tolerance, make sure you understand the 1 important warning sign
With trailing twelve month losses of CNY 373.4m, mixed half year profitability and a premium P/S multiple, the recent earnings profile looks inconsistent and fragile.
If you want ideas with clearer fundamentals and potentially more resilient financial profiles, start by checking companies in the solid balance sheet and fundamentals stocks screener (382 results) to see how stronger balance sheets can change the risk equation.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Contact Us
Contact Number :+852 3852 8500
English